Rachel Cowan Stubbs, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 11382 N Jacob Smart Blvd Ste D, Ridgeland, SC 29936 Phone: 843-441-9415 Fax: 843-305-6107 |
Kathleen R. Watson, FNP. B-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 124 A Boardwalk Drive, Recovery Concepts Llc, Ridgeland, SC 29936 Phone: 843-645-2770 Fax: 843-645-2771 |
Lori A. Lee, DNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1520 Grays Hwy, Ridgeland, SC 29936 Phone: 843-726-3979 |
Ramona M Pinckney, APRN Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 721 Okatie Highway 170, Ridgeland, SC 29936 Phone: 843-987-7400 |
Joann Lynn Brazil, APRN Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: Tricia Etheridge St Joseph Candler, 109 Green Street, Ridgeland, SC 29936 Phone: 843-726-6773 |
Mrs. Allison Ginette Jackson, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 719 N Okatie Hwy # 170, Ridgeland, SC 29936 Phone: 843-987-7400 |
Samantha Claybrook, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 11382 N Jacob Smart Blvd, Ridgeland, SC 29936 Phone: 843-645-9797 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Organon announced today that the U.S. Food and Drug Administration (FDA) approved Implanon (etonogestrel implant) 68mg, the first and only single-rod implantable contraceptive that is effective for up to three years.
A way to detect fragments of broken brain cells that leak into the bloodstream may help doctors more quickly and precisely treat people with severe head injuries or brain diseases, say researchers at the University of Florida's McKnight Brain Institute.
Two forms of skin and brain cancer respond very poorly to chemotherapy and radiation: melanoma and glioblastoma multiforme brain cancer.
The U.S. Food and Drug Administration (FDA) today licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.
› Verified 3 days ago